Ibiflo-S 50mcg/250mcg Nexcap

Short Description

Ibiflo-S 50mcg/250mcg Nexcap is a combination medicine used to treat asthma and chronic obstructive pulmonary disorder (COPD) by opening the airways and making it easier to breathe.

Dosage Form

Capsule

Introduction

Ibiflo-S 50mcg/250mcg Nexcap is a combination of Salmeterol and Fluticasone Propionate. It is used to treat asthma and chronic obstructive pulmonary disorder (COPD). Salmeterol is a long-acting bronchodilator that relaxes the muscles in the airways, while Fluticasone Propionate is a steroid that reduces inflammation. This combination helps in easing breathing. Common side effects are not listed, but it is important to consult a doctor for potential risks, especially during pregnancy and breastfeeding.

Take this medicine in the dose and duration as advised by your doctor.

Ibiflo-S 50mcg/250mcg Nexcap combines Salmeterol, a long-acting bronchodilator, and Fluticasone Propionate, a steroid. Salmeterol relaxes the muscles in the airways, widening them, while Fluticasone Propionate reduces inflammation by stopping the release of certain chemical messengers. Together, they make breathing easier.

This medicine is for inhalation only. The tablet should not be swallowed. It should be taken at the same time each day. It does not work right away and should not be used to relieve sudden breathing problems. Use your rescue inhaler to control sudden difficulty in breathing. Dry mouth may occur as a side effect. Frequent mouth rinses, good oral hygiene, increased water intake, and sugarless candy may help. Gargle with warm water after each inhalation to avoid any fungal infections in your mouth and throat. Take the first dose of this medicine under medical supervision as it may cause wheezing or tightening of the airways (bronchospasm) immediately after using. Your doctor may regularly monitor your blood potassium level as low oxygen level in the blood (hypoxia) and medicines such as Ibiflo-S 50mcg/250mcg Nexcap can lower blood potassium level. Only miniscule amounts of Ibiflo-S 50mcg/250mcg Nexcap may get absorbed into the bloodstream after inhalation. Hence, serious side effects are unlikely.